CONCIERGE CLINICAL TRIALS Trademark
Trademark Overview
On Thursday, October 17, 2024, a trademark application was filed for CONCIERGE CLINICAL TRIALS with the United States Patent and Trademark Office. The USPTO has given the CONCIERGE CLINICAL TRIALS trademark a serial number of 98807788. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, April 30, 2025. This trademark is owned by Concierge Clinical Trials, Inc.. The CONCIERGE CLINICAL TRIALS trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials, recruiting patients for trials and proceeding through the drug protocols, collection of data and reporting same to drug companies; Computerized database management, namely, editing, evaluating and processing data for third parties; performance of clinical studies, namely, managing clinical trials and studies of pharmaceutical and biotechnology products to the order and specification of drug companies; Recruitment advertisement services, namely, recruiting patients for participation in clinical trials for the testing of drugs
Scientific investigations for medical, drug and chemical compounds efficacy purposes; Providing medical and scientific research information in the field of drugs, compounds and clinical trials; Providing medical and scientific research, namely, conducting investigations and clinical trials for drug companies; Consulting services in the field of clinical trial investigations and research for pre-approved and post-approved compounds or drugs; Consulting services in the field of pharmaceutical research and development; Technical research in the field of pharmaceutical studies; Scientific research in the nature of conducting investigations and clinical trials for drug companies; Pharmaceutical product, investigations and clinical trials evaluation; Pharmaceutical research services; Pharmaceutical research and development
General Information
| Serial Number | 98807788 |
| Word Mark | CONCIERGE CLINICAL TRIALS |
| Filing Date | Thursday, October 17, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Wednesday, April 30, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the words CONCIERGE and CLINICAL TRIALS with two crossed keys. The bow portions of the keys have integrated capsule designs. The lining shown in the key designs is a feature of the mark. |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials, recruiting patients for trials and proceeding through the drug protocols, collection of data and reporting same to drug companies; Computerized database management, namely, editing, evaluating and processing data for third parties; performance of clinical studies, namely, managing clinical trials and studies of pharmaceutical and biotechnology products to the order and specification of drug companies; Recruitment advertisement services, namely, recruiting patients for participation in clinical trials for the testing of drugs |
| Goods and Services | Scientific investigations for medical, drug and chemical compounds efficacy purposes; Providing medical and scientific research information in the field of drugs, compounds and clinical trials; Providing medical and scientific research, namely, conducting investigations and clinical trials for drug companies; Consulting services in the field of clinical trial investigations and research for pre-approved and post-approved compounds or drugs; Consulting services in the field of pharmaceutical research and development; Technical research in the field of pharmaceutical studies; Scientific research in the nature of conducting investigations and clinical trials for drug companies; Pharmaceutical product, investigations and clinical trials evaluation; Pharmaceutical research services; Pharmaceutical research and development |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 17, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 17, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Concierge Clinical Trials, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Beverly Hills, CA 90210 |
Trademark Events
| Event Date | Event Description |
| Thursday, October 17, 2024 | NEW APPLICATION ENTERED |
| Saturday, April 19, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Saturday, April 19, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 21, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, April 30, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, April 30, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 30, 2025 | NON-FINAL ACTION E-MAILED |
